SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jenburkt Pharma - Quaterly Results

01 Aug 2022 Evaluate
The revenue for the June 2022 quarter is pegged at Rs. 311.32 millions, about 14.54% up against Rs. 271.80 millions recorded during the year-ago period.Good  Net Profit growth of 27.99% reported above the corresponding previous quarter figure of Rs. 46.51 millions to Rs. 59.53 millioins.The company reported a good operating profit of 84.15 millions compared to 65.55 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 311.32 271.80 14.54 311.32 271.80 14.54 1239.80 1092.94 13.44
Other Income 11.43 11.95 -4.35 11.43 11.95 -4.35 49.49 43.08 14.88
PBIDT 84.15 65.55 28.38 84.15 65.55 28.38 322.04 241.52 33.34
Interest 0.87 1.03 -15.53 0.87 1.03 -15.53 4.35 4.74 -8.23
PBDT 83.28 64.52 29.08 83.28 64.52 29.08 317.69 236.78 34.17
Depreciation 5.35 4.34 23.27 5.35 4.34 23.27 18.99 20.35 -6.68
PBT 77.93 60.18 29.49 77.93 60.18 29.49 298.70 216.43 38.01
TAX 18.40 13.67 34.60 18.40 13.67 34.60 75.74 51.39 47.38
Deferred Tax -0.83 -0.61 36.07 -0.83 -0.61 36.07 2.96 -3.91 -175.70
PAT 59.53 46.51 27.99 59.53 46.51 27.99 222.96 165.04 35.09
Equity 45.89 45.89 0.00 45.89 45.89 0.00 45.89 45.89 0.00
PBIDTM(%) 27.03 24.12 12.08 27.03 24.12 12.08 25.98 22.10 17.54

Jenburkt Pharma Share Price

1025.60 6.35 (0.62%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×